Covariates | Elements | Coefficient | Standard Error | t | P | 95% Confidence Interval | |
---|---|---|---|---|---|---|---|
Sample size | – | 0.01095 | 0.00551 | 1.99000 | 0.05300 | −0.00015 | 0.02205 |
BMI | – | 0.96000 | 0.34400 | −0.25631 | 0.72067 | 0.96000 | 0.34400 |
Age | – | 0.79053 | 0.32494 | 2.43000 | 0.01900 | 0.13607 | 1.44500 |
NOS | – | −0.57894 | 0.30767 | −1.88000 | 0.06600 | −1.19861 | 0.04073 |
Development | – | −1.83779 | 1.08681 | −1.69000 | 0.09800 | −4.02674 | 0.35115 |
regions | America | −1.15015 | 1.41992 | −0.81000 | 0.42200 | −4.01001 | 1.70972 |
Asia | −0.18814 | 1.01291 | −0.19000 | 0.85300 | −2.22825 | 1.85196 | |
Europe | – | – | – | – | – | – | |
Severity | All | −0.18343 | 1.27352 | −0.14000 | 0.88600 | −2.74843 | 2.38157 |
mild | −0.45801 | 1.38464 | −0.33000 | 0.74200 | −3.24681 | 2.33079 | |
moderate | −0.81363 | 1.51188 | −0.54000 | 0.59300 | −3.85871 | 2.23145 | |
moderate to severe | −0.20049 | 1.32277 | −0.15000 | 0.88000 | −2.86469 | 2.46371 | |
severe | −0.29741 | 1.21544 | −0.24000 | 0.80800 | −2.74542 | 2.15061 | |
mild to moderate | – | – | – | – | – | – | |
Method | CLIA | 0.21982 | 2.64027 | 0.08000 | 0.93400 | −5.09796 | 5.53759 |
ELISA | −3.70431 | 1.97035 | −1.88000 | 0.06700 | −7.67281 | 0.26418 | |
ECLIA | – | – | – | – | – | – | |
Specimen | Exhaled breath condensate | 2.90545 | 2.75026 | 1.06000 | 0.29600 | −2.63385 | 8.44475 |
PBMC | −3.25580 | 3.41251 | −0.95000 | 0.34500 | −10.12894 | 3.61734 | |
Pharyngeal lavage | 0.79203 | 2.68878 | 0.29000 | 0.77000 | −4.62345 | 6.20751 | |
Plasma | −0.27113 | 2.43064 | −0.11000 | 0.91200 | −5.16669 | 4.62444 | |
Saliva | 0.32275 | 2.90335 | 0.11000 | 0.91200 | −5.52490 | 6.17041 | |
Serum | 0.60803 | 2.45687 | 0.25000 | 0.80600 | −4.34035 | 5.55641 | |
Gingival crevicular fluid | – | – | – | – | – | – | |
Gender | – | −0.18789 | 0.35411 | −0.53000 | 0.59800 | −0.90109 | 0.52531 |
All | – | 9.10716 | 4.37081 | 2.08000 | 0.04300 | 0.30389 | 17.91043 |